Literature DB >> 26121938

Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature.

Elodie Hanns1, Sylvie Job2, Pierre Coliat1, Christine Wasylyk3, Ludivine Ramolu1, Erwan Pencreach4, Meggy Suarez-Carmona5, Michael Herfs5, Sonia Ledrappier1, Christine Macabre1, Joseph Abecassis1, Bohdan Wasylyk3, Alain C Jung6.   

Abstract

OBJECTIVES: Human Papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OSCC) patients have improved prognosis compared to other head and neck (HNSCC) cancers. Since poor prognosis is associated with tumour hypoxia, we studied whether the hypoxic response is different in HPV-related cells and tumours.
MATERIAL AND METHODS: HPV-positive and -negative cells were incubated in hypoxia and analyzed by qRTPCR, western blotting and cell proliferation assays. Tumours formed by xenografting these cells in nude mice were studied by IHC. HNSCC patient samples were analyzed by unsupervised clustering of hypoxia-related gene expression, quantitative real-time PCR (qRTPCR) and immunohistochemical (IHC) detection of neo-blood vessels. RESULTS AND
CONCLUSION: HPV-positive and -negative cells responded differently to hypoxia, in terms of gene expression (HIF-1α, PHD-3, GLUT-1 and VEGF-A) and cell survival. Tumour xenografts formed by HPV-positive cells had fewer hypoxic areas than those formed by HPV-negative cells. HPV related tumours were less hypoxic, expressed lower levels of hypoxia-responsive genes, and had a higher density of neo-blood vessels. HPV-related OSCC display lower tumour hypoxia, which could be linked to the distinct intrinsic abilities of HPV-positive tumour cells to adapt to hypoxia and to their better prognosis.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gene expression; HPV; Head and neck squamous cell carcinoma; Hypoxia; Immunohistochemistry; Transcriptome

Mesh:

Year:  2015        PMID: 26121938     DOI: 10.1016/j.oraloncology.2015.06.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.

Authors:  Hongzheng Zhang; Sungjin Kim; Zhengjia Chen; Sreenivas Nannapaneni; Amy Y Chen; Charles E Moore; Gabriel Sica; Marina Mosunjac; Minh Ly T Nguyen; Gypsyamber D'Souza; Thomas E Carey; Lisa A Peterson; Jonathan B McHugh; Martin Graham; Christine M Komarck; Gregory T Wolf; Heather M Walline; Emily Bellile; James Riddell; Sara I Pai; David Sidransky; William H Westra; William N William; J Jack Lee; Adel K El-Naggar; Robert L Ferris; Raja Seethala; Jennifer R Grandis; Zhuo Georgia Chen; Nabil F Saba; Dong M Shin
Journal:  Head Neck       Date:  2017-09-25       Impact factor: 3.147

Review 2.  [Invasion and metastasis mechanism of human papillomavirus in head and neck squamous cell carcinomas].

Authors:  Guang-Xue Cui; Xiao-Lei Gao; Xin-Hua Liang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-10-01

Review 3.  Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review.

Authors:  Gregoire B Morand; Alina Diaconescu; Iman Ibrahim; Genevieve Lamarche; Juliana S Ruas; Jacqueline Dalfen; Michael P Hier; Moulay A Alaoui-Jamali; Mariana Maschietto; Sabrina Daniela da Silva
Journal:  Clin Exp Metastasis       Date:  2022-01-27       Impact factor: 5.150

4.  New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.

Authors:  Kevin David Shield; Claire Marant Micallef; Catherine de Martel; Isabelle Heard; Francis Megraud; Martyn Plummer; Jérôme Vignat; Freddie Bray; Isabelle Soerjomataram
Journal:  Eur J Epidemiol       Date:  2017-12-06       Impact factor: 8.082

5.  Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines.

Authors:  Jennifer Knuth; Shachi J Sharma; Nora Würdemann; Claudia Holler; Boyan K Garvalov; Till Acker; Claus Wittekindt; Steffen Wagner; Jens P Klussmann
Journal:  Oncotarget       Date:  2017-09-11

Review 6.  The Double-Edged Sword-How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer.

Authors:  Hao-Fan Wang; Sha-Sha Wang; Ya-Jie Tang; Yu Chen; Min Zheng; Ya-Ling Tang; Xin-Hua Liang
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

7.  Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer.

Authors:  Heleen Bollen; Julie van der Veen; Annouschka Laenen; Sandra Nuyts
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

Review 8.  HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies.

Authors:  Rüveyda Dok; Sandra Nuyts
Journal:  Cancers (Basel)       Date:  2016-03-29       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.